Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06630169
PHASE2
Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Sponsor: Aurion Biotech
View on ClinicalTrials.gov
Summary
The purpose of this study is to assess the safety and efficacy of cryopreserved AURN001 in patients with corneal edema secondary to endothelial dysfunction.
Official title: APANECA: A Prospective, Parallel-arm, Multi-Surgeon Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (2024-E002-C)
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2024-09-16
Completion Date
2025-10
Last Updated
2025-01-28
Healthy Volunteers
No
Conditions
Interventions
COMBINATION_PRODUCT
Cryopreserved AURN001
Corneal Endothelial Cells and Y27632
Locations (1)
Aurion Biotech site
San Salvador, El Salvador